Sahzene Yavuz is an Endocrinology/Metabolic physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 27 publications with 432 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
105 Desmond St
Sayre, PA 188402001
Telephone
201-421-9520Provider last certified this registry record 20 Apr 2024.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202511 payments
- Dexcom, Inc.Program year20253 payments
- Tandem Diabetes Care, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
69.4%RANK Ligand Inhibitor69.4%Denosumab99%Prolia1%Part D + Part B≥42 patientsMetabolism & gastrointestinal
18%Insulin Analog6.7%Lantus Solostar26%Novolog Flexpen15%Novolog13%Tresiba Flextouch U-10012%Insulin Lispro Kwikpen U-1007%Humalog Kwikpen U-1007%Basaglar Kwikpen U-1006%Humalog5%Tresiba Flextouch U-2005%Toujeo Solostar4%Part D<11 patientsGLP-1 receptor agonist5.7%Ozempic47%Mounjaro36%Trulicity17%Part D≥41 patients+ 5 more classes in this area
Hormonal (systemic)
10%l-Thyroxine7.8%Levothyroxine Sodium83%Synthroid13%Tirosint4%Part D<11 patientsParathyroid Hormone Analog1%Teriparatide63%Forteo37%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism
Frontiers in Endocrinology
2025 - MON-446 Immunotherapy Induced Thyroiditis Secondary to Nivolumab
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Ross, MD
SUNY Upstate Medical University
Andras Perl, MD
SUNY Upstate Medical University
Ruth Weinstock, MD
SUNY Upstate Medical University
Srikanth Yandrapalli, MD
SUNY Upstate Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”